vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and WEST BANCORPORATION INC (WTBA). Click either name above to swap in a different company.

WEST BANCORPORATION INC is the larger business by last-quarter revenue ($26.9M vs $26.6M, roughly 1.0× NeuroPace Inc). WEST BANCORPORATION INC runs the higher net margin — 39.2% vs -10.3%, a 49.5% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs 16.6%). WEST BANCORPORATION INC produced more free cash flow last quarter ($12.4M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 17.3%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

West Bancorporation Inc. is a regional financial holding company headquartered in the U.S. Midwest, primarily serving markets across Iowa and Minnesota. It provides a full suite of personal and commercial banking services, including deposit accounts, mortgage loans, business lending, and wealth management solutions for individual consumers, small-to-medium enterprises, and local organizational clients.

NPCE vs WTBA — Head-to-Head

Bigger by revenue
WTBA
WTBA
1.0× larger
WTBA
$26.9M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+7.2% gap
NPCE
23.9%
16.6%
WTBA
Higher net margin
WTBA
WTBA
49.5% more per $
WTBA
39.2%
-10.3%
NPCE
More free cash flow
WTBA
WTBA
$12.0M more FCF
WTBA
$12.4M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
17.3%
WTBA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NPCE
NPCE
WTBA
WTBA
Revenue
$26.6M
$26.9M
Net Profit
$-2.7M
$10.6M
Gross Margin
77.4%
Operating Margin
-6.6%
50.0%
Net Margin
-10.3%
39.2%
Revenue YoY
23.9%
16.6%
Net Profit YoY
48.0%
34.8%
EPS (diluted)
$-0.08
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
WTBA
WTBA
Q1 26
$26.9M
Q4 25
$26.6M
$24.2M
Q3 25
$27.4M
$25.0M
Q2 25
$23.5M
$23.8M
Q1 25
$22.5M
$23.1M
Q4 24
$21.5M
$20.9M
Q3 24
$21.1M
$20.3M
Q2 24
$19.3M
$19.6M
Net Profit
NPCE
NPCE
WTBA
WTBA
Q1 26
$10.6M
Q4 25
$-2.7M
$7.4M
Q3 25
$-3.5M
$9.3M
Q2 25
$-8.7M
$8.0M
Q1 25
$-6.6M
$7.8M
Q4 24
$-5.3M
$7.1M
Q3 24
$-5.5M
$6.0M
Q2 24
$-7.5M
$5.2M
Gross Margin
NPCE
NPCE
WTBA
WTBA
Q1 26
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Operating Margin
NPCE
NPCE
WTBA
WTBA
Q1 26
50.0%
Q4 25
-6.6%
39.6%
Q3 25
-9.5%
45.8%
Q2 25
-29.0%
43.4%
Q1 25
-22.9%
43.4%
Q4 24
-17.0%
30.9%
Q3 24
-20.1%
36.6%
Q2 24
-32.4%
32.6%
Net Margin
NPCE
NPCE
WTBA
WTBA
Q1 26
39.2%
Q4 25
-10.3%
30.7%
Q3 25
-12.8%
37.3%
Q2 25
-36.8%
33.5%
Q1 25
-29.3%
34.0%
Q4 24
-24.5%
34.0%
Q3 24
-25.9%
29.3%
Q2 24
-39.0%
26.5%
EPS (diluted)
NPCE
NPCE
WTBA
WTBA
Q1 26
$0.61
Q4 25
$-0.08
$0.44
Q3 25
$-0.11
$0.55
Q2 25
$-0.26
$0.47
Q1 25
$-0.21
$0.46
Q4 24
$-0.16
$0.41
Q3 24
$-0.19
$0.35
Q2 24
$-0.26
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
WTBA
WTBA
Cash + ST InvestmentsLiquidity on hand
$61.1M
$362.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
$270.7M
Total Assets
$105.6M
$4.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
WTBA
WTBA
Q1 26
$362.0M
Q4 25
$61.1M
$471.1M
Q3 25
$60.0M
$232.9M
Q2 25
$62.1M
$345.2M
Q1 25
$66.3M
Q4 24
$52.8M
$243.5M
Q3 24
$56.8M
Q2 24
$55.5M
Stockholders' Equity
NPCE
NPCE
WTBA
WTBA
Q1 26
$270.7M
Q4 25
$19.0M
$266.0M
Q3 25
$18.5M
$255.1M
Q2 25
$19.4M
$240.9M
Q1 25
$24.3M
$237.9M
Q4 24
$8.0M
$227.9M
Q3 24
$9.8M
$235.4M
Q2 24
$9.9M
$223.9M
Total Assets
NPCE
NPCE
WTBA
WTBA
Q1 26
$4.0B
Q4 25
$105.6M
$4.1B
Q3 25
$107.3M
$4.0B
Q2 25
$106.1M
$4.1B
Q1 25
$110.2M
$4.0B
Q4 24
$94.6M
$4.0B
Q3 24
$96.3M
$4.0B
Q2 24
$94.4M
$4.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
WTBA
WTBA
Operating Cash FlowLast quarter
$506.0K
$12.9M
Free Cash FlowOCF − Capex
$409.0K
$12.4M
FCF MarginFCF / Revenue
1.5%
46.0%
Capex IntensityCapex / Revenue
0.4%
1.8%
Cash ConversionOCF / Net Profit
1.22×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$79.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
WTBA
WTBA
Q1 26
$12.9M
Q4 25
$506.0K
$46.5M
Q3 25
$-1.9M
$11.4M
Q2 25
$-2.1M
$13.5M
Q1 25
$-7.5M
$9.7M
Q4 24
$-4.8M
$39.8M
Q3 24
$-1.7M
$12.9M
Q2 24
$-3.9M
$10.0M
Free Cash Flow
NPCE
NPCE
WTBA
WTBA
Q1 26
$12.4M
Q4 25
$409.0K
$43.2M
Q3 25
$-2.0M
$10.8M
Q2 25
$-2.3M
$12.8M
Q1 25
$-7.5M
$8.3M
Q4 24
$-4.8M
$13.7M
Q3 24
$-1.8M
$7.0M
Q2 24
$-4.0M
$2.7M
FCF Margin
NPCE
NPCE
WTBA
WTBA
Q1 26
46.0%
Q4 25
1.5%
178.3%
Q3 25
-7.2%
43.0%
Q2 25
-9.6%
53.6%
Q1 25
-33.4%
35.7%
Q4 24
-22.5%
65.6%
Q3 24
-8.7%
34.2%
Q2 24
-20.6%
14.0%
Capex Intensity
NPCE
NPCE
WTBA
WTBA
Q1 26
1.8%
Q4 25
0.4%
13.7%
Q3 25
0.1%
2.6%
Q2 25
0.7%
3.2%
Q1 25
0.2%
6.5%
Q4 24
0.2%
125.3%
Q3 24
0.5%
29.4%
Q2 24
0.3%
37.1%
Cash Conversion
NPCE
NPCE
WTBA
WTBA
Q1 26
1.22×
Q4 25
6.26×
Q3 25
1.23×
Q2 25
1.70×
Q1 25
1.24×
Q4 24
5.61×
Q3 24
2.17×
Q2 24
1.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons